Valuation: MiniMed Group, Inc.

Market Cap 5.68B 4.87B 4.55B 4.17B 7.85B 543B 7.98B 53.67B 21.02B 272B 21.32B 20.86B 900B P/E 2027 *
32.3x
P/E 2028 * 31.8x
Enterprise Value 5.29B 4.53B 4.23B 3.88B 7.3B 505B 7.43B 49.96B 19.56B 253B 19.85B 19.42B 838B EV / Sales 2027 *
1.54x
EV / Sales 2028 * 1.37x
Free-Float
9.28%
Yield 2027 *
-
Yield 2028 * -
1 day+4.44%
1 week-2.32%
Current month+12.02%
1 month+19.43%
3 months+85.67%
1 week 19.19
Extreme 19.1875
20.42
1 month 15.96
Extreme 15.96
20.88
Current year 10.65
Extreme 10.65
20.88
1 year 10.65
Extreme 10.65
20.88
3 years 10.65
Extreme 10.65
20.88
5 years 10.65
Extreme 10.65
20.88
10 years 10.65
Extreme 10.65
20.88
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+4.44%-2.32% - - 5.44B
+0.64%+0.08%+29.08%+30.10% 12.79B
+1.45%+2.01%+18.38%+33.61% 6.87B
+3.12%+4.58%+55.70%+49.52% 6.82B
+1.73%+5.78%-20.33%+62.13% 4.7B
-0.54%-4.11%-28.09%-23.16% 3.85B
+5.57%+3.47%+50.79%-41.38% 2.01B
-0.97%-8.52%+45.71%-10.13% 1.66B
-2.73%+1.33%-34.03%+121.99% 1.63B
-2.20%-3.68%-31.08%-43.94% 1.31B
Average +1.04%+0.38%+9.57%+19.86% 4.71B
Weighted average by Cap. +1.51%+0.82%+18.14%+28.78%

Financials

2027 *2028 *
Net sales 3.42B 2.94B 2.74B 2.51B 4.73B 327B 4.81B 32.35B 12.67B 164B 12.85B 12.57B 542B 3.71B 3.18B 2.97B 2.73B 5.13B 355B 5.21B 35.06B 13.73B 178B 13.93B 13.63B 588B
Net income 175M 150M 140M 129M 242M 16.73B 246M 1.65B 648M 8.39B 657M 643M 27.75B 207M 178M 166M 152M 286M 19.81B 291M 1.96B 767M 9.94B 778M 761M 32.85B
Net Debt -393M -337M -315M -289M -543M -37.53B -552M -3.71B -1.45B -18.82B -1.47B -1.44B -62.23B -601M -515M -481M -441M -830M -57.42B -844M -5.68B -2.22B -28.8B -2.26B -2.21B -95.21B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-08-19 US$20.22 +4.44% 1,619,383
26-08-18 US$19.36 -0.87% 1,501,753
26-08-17 US$19.53 -3.08% 1,516,423
26-08-14 US$20.15 +0.65% 1,069,158
26-08-13 US$20.02 -3.29% 1,092,078
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
20.22USD
Average target price
20.83USD
Spread / Average Target
+3.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock